PMVP
PMV Pharmaceuticals, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
PMV Pharmaceuticals, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
No thesis.
PMV Pharmaceuticals, Inc.
1.31
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BML Capital ManagementBML | $7.1M | 15.45% | +0.19% | |
| 2 | Tang Capital ManagementTang | $5.7M | 12.31% | 0.00% | |
| 3 | Sio Capital ManagementSio | $3.5M | 7.64% | −14.38% | |
| 4 | Euclidean CapitalEuclidean Capital | $3.5M | 7.62% | 0.00% | |
| 5 | Adage Capital Partners GPAdage Capital Partners GP | $3.2M | 6.84% | +26.88% | |
| 6 | Acadian Asset ManagementAcadian | $3.0M | 6.42% | 0.00% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $2.7M | 5.83% | +1.88% | |
| 8 | Arrowpoint Asset ManagementArrowpoint | $2.6M | 5.68% | −31.79% | |
| 9 | Two Sigma InvestmentsTwo Sigma | $2.6M | 5.66% | +3.69% | |
| 10 | Eversept PartnersEversept Partners | $2.5M | 5.48% | −19.48% | |
| 11 | BlackRockBlackRockindex-like | $1.2M | 2.67% | +5.20% | |
| 12 | Stonepine Capital ManagementStonepine | $718,355 | 1.55% | −24.29% | |
| 13 | Geode Capital ManagementGeodeindex-like | $634,624 | 1.37% | −4.59% | |
| 14 | Aldebaran CapitalAldebaran Capital | $626,359 | 1.36% | −1.25% | |
| 15 | Bridgeway Capital ManagementBridgeway | $574,663 | 1.24% | 0.00% | |
| 16 | BIT CapitalBIT Capital | $546,124 | 1.18% | +229.86% | |
| 17 | Verdad AdvisersVerdad | $485,564 | 1.05% | +101.13% | |
| 18 | Walleye CapitalWalleye Capital | $449,830 | 0.97% | 0.00% | |
| 19 | Assenagon Asset ManagementAssenagon | $442,204 | 0.96% | −8.53% | |
| 20 | Marshall WaceMarshall Wace | $430,956 | 0.93% | −25.91% | |
| 21 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $341,399 | 0.74% | −14.54% | |
| 22 | Citadel AdvisorsCitadel | $334,475 | 0.72% | +93.27% | |
| 23 | Bank of AmericaBank of America | $321,747 | 0.70% | −0.18% | |
| 24 | ADAR1 Capital ManagementADAR1 | $269,351 | 0.58% | −12.99% | |
| 25 | State StreetState Streetindex-like | $245,459 | 0.53% | 0.00% |
63 managers report $46.2M of PMV Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 11 of them hold 80% of it; BML is largest at 15.45%.
Largest filed tie
—
Expected move
No implied move.
No implied move.
No implied move.